Hugel Inc

Hugel Inc. is bringing its clinical cosmetics brand WELLAGE to Sephora stores across the U.S. through a strategic partnership with OLIVE YOUNG. Starting August 20, five flagship products from WELLAGE's Real Hyaluronic line, including the one day kit, ampoule, toner, cream and mask, will be available at OLIVE YOUNG's K-Beauty Edit display in Sephora stores. WELLAGE will also participate in a pop-up truck event hosted by OLIVE YOUNG, beginning August 20 in front of Sephora stores in key U.S. markets including New York, Texas, and Florida. Hugel will distribute 10ml miniatures of the Real Hyaluronic Blue 100 Ampoule, winner of the Essence/Serum category at the 2025 Olive Young Awards, to let local consumers experience the product. Carrie Strom, President and Global CEO of Hugel, said the company will actively expand awareness of K-beauty across North America and worldwide.

Hugel Inc. reported record first-half 2026 earnings, with consolidated net sales jumping 27.2% on-year to KRW254.5 billion, operating profit rising 8.4% to KRW103.7 billion, and net income climbing 23.5% to KRW85.3 billion. The performance was primarily driven by solid demand for botulinum toxin, which saw first-half net sales increase 46.6% on-year to KRW149.4 billion. Global net sales of botulinum toxin and hyaluronic acid dermal fillers and skinboosters reached KRW162.1 billion, accounting for about 64% of total net sales, while the cosmetics and other businesses posted KRW39 billion, up 31.7%. Second-quarter operating profit remained largely unchanged on-year at KRW56 billion, reflecting strategic investments to support long-term growth including the rollout of U.S. direct sales operations. The company saw balanced growth across markets, with first-half net sales in the Americas more than doubling on-year and both Asia-Pacific and Europe & other markets increasing by the mid-to-high 20% range.

Hugel reinforced its position in the global aesthetics market at the first-ever AMWC KOREA, held June 19–20 in Seoul. The company won the Best Injectables for Skin Anti-aging award and highlighted its flagship botulinum toxin product Letybo through a luncheon symposium featuring experts from Korea and the U.S. Hugel also hosted its signature L.E.A.D. education program with live demonstrations and a global networking event attended by about 140 participants from the U.S., Canada, Australia, and Europe. President and Global CEO Carrie Strom said the company will continue deepening collaboration with healthcare professionals and partners worldwide.